
High Content Screening Market by Product (Accessories, Consumables, Instruments), Application (Explorative Screening, Neurobiology, Oncology), End User - Global Forecast 2024-2030
Description
High Content Screening Market by Product (Accessories, Consumables, Instruments), Application (Explorative Screening, Neurobiology, Oncology), End User - Global Forecast 2024-2030
The High Content Screening Market size was estimated at USD 840.72 million in 2023 and expected to reach USD 926.25 million in 2024, at a CAGR 10.26% to reach USD 1,666.38 million by 2030.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the High Content Screening Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the High Content Screening Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the High Content Screening Market, highlighting leading vendors and their innovative profiles. These include Advanced Solutions, Inc., Agilent Technologies, Inc., Aurora Biomed Inc., Axxam S.p.A, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., Danaher Corporation, Genedata AG, Merck KGaA, Ncardia Services BV, Perkinelmer, Inc., Sartorius AG, SPT Labtech Ltd., Tecan Trading AG, and Thermo Fisher Scientific Inc..
Market Segmentation & Coverage
This research report categorizes the High Content Screening Market to forecast the revenues and analyze trends in each of the following sub-markets:
Product
Accessories
Consumables
Microplates
Reagents & Assay Kits
Instruments
Cell Imaging & Analysis Systems
Flow Cytometers
Services
Software
Application
Explorative Screening
Neurobiology
Oncology
Target Validation
Toxicology
End User
Biotechnology
Educational Institutions
Government Organizations
Independent CRO
Pharmaceutical & Healthcare
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the High Content Screening Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the High Content Screening Market?
3. What are the technology trends and regulatory frameworks in the High Content Screening Market?
4. What is the market share of the leading vendors in the High Content Screening Market?
5. Which modes and strategic moves are suitable for entering the High Content Screening Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
184 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. High Content Screening Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Growing application of high-content screening in life science research
- 5.1.1.2. Advancements in the imaging solutions
- 5.1.1.3. Favorable government regulations and investment in the developed countries
- 5.1.2. Restraints
- 5.1.2.1. Higher cost of high content screening
- 5.1.3. Opportunities
- 5.1.3.1. Technological advancement in the high throughput screening for drug discovery
- 5.1.3.2. Amalgamation of high throughput 3D cell-based models with advances in material sciences
- 5.1.4. Challenges
- 5.1.4.1. Lack of healthcare infrastructure and investments for HCS in emerging economies
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. High Content Screening Market, by Product
- 6.1. Introduction
- 6.2. Accessories
- 6.3. Consumables
- 6.4.1. Microplates
- 6.4.2. Reagents & Assay Kits
- 6.4. Instruments
- 6.5.1. Cell Imaging & Analysis Systems
- 6.5.2. Flow Cytometers
- 6.5. Services
- 6.6. Software
- 7. High Content Screening Market, by Application
- 7.1. Introduction
- 7.2. Explorative Screening
- 7.3. Neurobiology
- 7.4. Oncology
- 7.5. Target Validation
- 7.6. Toxicology
- 8. High Content Screening Market, by End User
- 8.1. Introduction
- 8.2. Biotechnology
- 8.3. Educational Institutions
- 8.4. Government Organizations
- 8.5. Independent CRO
- 8.6. Pharmaceutical & Healthcare
- 9. Americas High Content Screening Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
- 10. Asia-Pacific High Content Screening Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
- 11. Europe, Middle East & Africa High Content Screening Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
- 12. Competitive Landscape
- 12.1. FPNV Positioning Matrix
- 12.2. Market Share Analysis, By Key Player
- 12.3. Competitive Scenario Analysis, By Key Player
- 13. Competitive Portfolio
- 13.1. Key Company Profiles
- 13.1.1. Advanced Solutions, Inc.
- 13.1.2. Agilent Technologies, Inc.
- 13.1.3. Aurora Biomed Inc.
- 13.1.4. Axxam S.p.A
- 13.1.5. Becton, Dickinson and Company
- 13.1.6. Bio-Rad Laboratories, Inc.
- 13.1.7. Cell Signaling Technology, Inc.
- 13.1.8. Danaher Corporation
- 13.1.9. Genedata AG
- 13.1.10. Merck KGaA
- 13.1.11. Ncardia Services BV
- 13.1.12. Perkinelmer, Inc.
- 13.1.13. Sartorius AG
- 13.1.14. SPT Labtech Ltd.
- 13.1.15. Tecan Trading AG
- 13.1.16. Thermo Fisher Scientific Inc.
- 13.2. Key Product Portfolio
- 14. Appendix
- 14.1. Discussion Guide
- 14.2. License & Pricing
- FIGURE 1. HIGH CONTENT SCREENING MARKET RESEARCH PROCESS
- FIGURE 2. HIGH CONTENT SCREENING MARKET SIZE, 2023 VS 2030
- FIGURE 3. HIGH CONTENT SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. HIGH CONTENT SCREENING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. HIGH CONTENT SCREENING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. HIGH CONTENT SCREENING MARKET DYNAMICS
- FIGURE 7. HIGH CONTENT SCREENING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
- FIGURE 8. HIGH CONTENT SCREENING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. HIGH CONTENT SCREENING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
- FIGURE 10. HIGH CONTENT SCREENING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. HIGH CONTENT SCREENING MARKET SIZE, BY END USER, 2023 VS 2030 (%)
- FIGURE 12. HIGH CONTENT SCREENING MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. AMERICAS HIGH CONTENT SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 14. AMERICAS HIGH CONTENT SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. UNITED STATES HIGH CONTENT SCREENING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 16. UNITED STATES HIGH CONTENT SCREENING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. ASIA-PACIFIC HIGH CONTENT SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. ASIA-PACIFIC HIGH CONTENT SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HIGH CONTENT SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HIGH CONTENT SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. HIGH CONTENT SCREENING MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 22. HIGH CONTENT SCREENING MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.